Association of hippocampal atrophy with cerebrospinal fluid antibodies against the nr2 subtype of the N-methyl- D -aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome

Arthritis and Rheumatology

Volumn 66, Issue 12, 2014, Pages 3387-3394

  Lauvsnes, Maria B ^a   Beyer, Mona K ^b   Kvaløy, Jan Terje ^a   Greve, Ole J ^a   Appenzeller, Simone ^c   Kvivik, Ingeborg ^a   Harboe, Erna ^a   Tjensvoll, Anne B ^a   Gøransson, Lasse G ^a,d   Omdal, Roald ^a,d  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2; UNCLASSIFIED DRUG; AUTOANTIBODY;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL EXAMINATION; FEMALE; GRAY MATTER; HIPPOCAMPAL ATROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; AGED; ATROPHY; HIPPOCAMPUS; IMAGE PROCESSING; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ATROPHY; AUTOANTIBODIES; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE; SJOGREN'S SYNDROME;

EID: 84911994395     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38852     Document Type: Article

References (36)

1. Harboe E, Tjensvoll AB, Maroni S, Goransson LG, Greve OJ, Beyer MK, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study. Ann Rheum Dis 2009; 68: 1541-6.
2. Segal BM, Mueller BA, Zhu X, Prosser R, Pogatchnik B, Holker E, et al. Disruption of brain white matter microstructure in primary Sjögren's syndrome: evidence from diffusion tensor imaging. Rheumatology (Oxford) 2010; 49: 1530-9.
3. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83: 280-91.
4. Yoshio T, Hirata D, Onda K, Nara H, Minota S,. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol 2005; 32: 34-9.
5. Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA,. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 735-41.
6. Hirohata S, Kanai Y, Mitsuo A, Tokano Y, Hashimoto H,. Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis: a multicenter retrospective study. Clin Rheumatol 2009; 28: 1319-23.
7. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI,. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005; 12: 392-8.
8. Arinuma Y, Yanagida T, Hirohata S,. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1130-5.
9. Lauvsnes MB, Maroni SS, Appenzeller S, Beyer MK, Greve OJ, Kvaloy JT, et al. Memory dysfunction in primary Sjögren's syndrome is associated with anti-NR2 antibodies [published erratum appears in Arthritis Rheumatol 2014;66:989]. Arthritis Rheum 2013; 65: 3209-17.
10. Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T, et al. Anti-N-methyl- D -aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2505-14.
11. Hanly JG, Robichaud J, Fisk JD,. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 2006; 33: 1553-8.
12. Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, et al, for the Systemic Lupus International Collaborating Clinics. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008; 58: 843-53.
13. Kozora E, West SG, Maier SF, Filley CM, Arciniegas DB, Brown M, et al. Antibodies against N-methyl- D -aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci 2010; 295: 87-91.
14. Harrison MJ, Ravdin LD, Lockshin MD,. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2515-22.
15. Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, et al. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol 2010; 37: 2032-8.
16. Cooke SF, Bliss TV,. Plasticity in the human central nervous system. Brain 2006; 129: 1659-73.
17. Barkus C, McHugh SB, Sprengel R, Seeburg PH, Rawlins JN, Bannerman DM,. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol 2010; 626: 49-56.
18. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B,. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189-93.
19. Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, et al. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A 2010; 107: 18569-74.
20. 2+ influx in systemic lupus erythematosus. Arthritis Rheum 2011; 63: 3952-9.
21. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity: antibody impairs memory. Immunity 2004; 21: 179-88.
22. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006; 103: 19854-9.
23. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B,. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006; 103: 678-83.
24. Appenzeller S, Carnevalle AD, Li LM, Costallat LT, Cendes F,. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis 2006; 65: 1585-9.
25. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
26. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
27. Ashburner J, Friston KJ,. Unified segmentation. Neuroimage 2005; 26: 839-51.
28. Ashburner J, Friston KJ,. Voxel-based morphometry-the methods. Neuroimage 2000; 11: 805-21.
29. Maldjian JA, Laurienti PJ, Burdette JH,. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004; 21: 450-5.
30. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH,. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-9.
31. Friston KJ, Worsley KJ, Frackowiak RS, Mazziotta JC, Evans AC,. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1993; 1: 210-20.
32. Ozawa S, Kamiya H, Tsuzuki K,. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998; 54: 581-618.
33. Matus S, Burgos PV, Bravo-Zehnder M, Kraft R, Porras OH, Farias P, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007; 204: 3221-34.
34. Diamond B, Kowal C, Huerta PT, Aranow C, Mackay M, DeGiorgio LA, et al. Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv Immunol 2006; 89: 289-320.
35. Stonnington CM, Tan G, Kloppel S, Chu C, Draganski B, Jack CR Jr, et al. Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease. Neuroimage 2008; 39: 1180-5.et al.
36. Aranow C, Diamond B, Mackay M,. Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 2010; 36: 187-201, x-xi.